伊萨夫可纳为急性髓性白血病患者提供有效和耐受的抗真菌预防
Cameron J Hunter1, Andrew Chou2, Heidi Roeder3
1Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA.
Leukemia research
|December 9, 2025
概括
伊萨夫可纳在急性髓性白血病 (AML) 患者的抗真菌预防中提供了比伏利可纳更好的副作用概况. 这两种药物在预防侵入性真菌感染 (IFI) 方面表现出相似的疗效.
科学领域:
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 沃里科纳是一种标准的抗真菌预防剂 (AFP),用于中性衰竭期间急性髓性白血病 (AML) 患者.
- 沃里康纳的使用受到副作用的限制,如转氨酶升高,视力障碍和药物相互作用 (DDI).
- 伊萨夫可纳呈现出一种具有潜在更有利副作用概况的替代性AFP.
研究的目的:
- 为了在AML患者中比较isavuconazole和voriconazole之间的导致AFP撤销的并发症率.
- 为了评估和比较两种醇剂之间的侵入性真菌感染 (IFI) 和整体存活率 (OS) 的发生率.
- 评估 isavuconazole 作为 AML 的抗真菌预防方案的安全性和有效性.
主要方法:
- 追溯分析比较ISAVUCONAZOLE (n=63) 和VORICONAZOLE (n=215) 在AML患者的初始AFP.
- 由于不良事件或其他原因而导致的AFP停止率的比较.
- 在仅使用伊萨夫康纳 (n=41) 或沃里康纳 (n=90) 的小组中分析了IFI率,突破性IFI (bIFI),无IFI生存率 (IFI-FS) 和中位数整体生存率 (OS).
主要成果:
- 沃里科纳与因转氨酶升高 (p=0.019),视力障碍 (p=0.002) 和DDI (p=0.002) 的AFP中止率显著更高有关.
- 因拒绝覆盖或高成本 (p<0.0001) 而更频繁地停止服用伊萨夫可纳.
- 在两种醇剂之间,IFI,bIFI,IFI-FS和OS的比率是可比的.
结论:
- 与沃里科纳相比,伊萨武科纳在AML患者的抗真菌预防中显示出更好的副作用概况.
- 伊萨夫可纳是一种有效的AFP药物,在预防IFI方面,其疗效与沃里可纳相当.
- 伊萨夫可纳应该被认为是AML患者有前途的替代性AFP选择,平衡疗效和耐受性.
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.3K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
576
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
576
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
790
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
790
Drug Dosage Regimen: Overview
4.3K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.3K


